Racho, Michelle .
HRN: 26-59-54 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2025
CEFUROXIME 1.5GM (VIAL)
04/12/2025
04/18/2025
IV
1.5g
Q8
LTCS
Waiting Final Action
04/12/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/12/2025
04/18/2025
IV
500mg
Q8
Cs
Waiting Final Action
04/13/2025
CEFUROXIME 500MG (TAB)
04/13/2025
04/20/2025
PO
500mg
Bid
LTCS
Waiting Final Action